Food Addit Contam Part A Chem Anal Control Expo Risk AssessFood Addit Contam Part A Chem Anal Control Expo Risk AssesstfacFood Additives & Contaminants. Part A, Chemistry, Analysis, Control, Exposure & Risk Assessment1944-00491944-0057Taylor & Francis23767939372567010.1080/19440049.2013.789558Research ArticleHuman aflatoxin exposure in Kenya, 2007: a cross-sectional studyYardEllen E.a∗DanielJohnni H.aLewisLauren S.aRybakMichael E.aPaliakovEkaterina M.aKimAndrea A.bMontgomeryJoel M.bBunnellRebeccabAbudoMamo UmurocAkhwaleWilliscBreimanRobert F.bSharifShahnaaz K.c Centers for Disease Control and Prevention, National Center for Environmental Health, Chamblee, GA, USA Centers for Disease Control and Prevention, Center for Global Health, Nairobi, Kenya Kenya Ministry of Public Health and Sanitation, Nairobi, Kenya Corresponding author. Email: eyard@cdc.gov
This work was authored as part of Ellen E. Yard, Johnni H. Daniel, Lauren S. Lewis, Michael E. Rybak, Ekaterina M. Paliakov, Andrea A. Kim, Joel M. Montgomery, Rebecca Bunnell, and Robert F. Breiman's official duties as Employees of the United States Government and is therefore a work of the United States Government. In accordance with 17 USC. 105, no copyright protection is available for such works under US Law.
Mamo Umuro Abudo, Willis Akhwale, and Shahnaaz K. Sharif waive their assertion of copyright but not their right to be named as authors of the paper.
Aflatoxins contaminate approximately 25% of agricultural products worldwide. They can cause liver failure and liver cancer. Kenya has experienced multiple aflatoxicosis outbreaks in recent years, often resulting in fatalities. However, the full extent of aflatoxin exposure in Kenya has been unknown. Our objective was to quantify aflatoxin exposure across Kenya. We analysed aflatoxin levels in serum specimens from the 2007 Kenya AIDS Indicator Survey – a nationally representative, cross-sectional serosurvey. KAIS collected 15,853 blood specimens. Of the 3180 human immunodeficiency virus-negative specimens with ≥1 mL sera, we randomly selected 600 specimens stratified by province and sex. We analysed serum specimens for aflatoxin albumin adducts by using isotope dilution MS/MS to quantify aflatoxin B1-lysine, and normalised with serum albumin. Aflatoxin concentrations were then compared by demographic, socioeconomic and geographic characteristics. We detected serum aflatoxin B1-lysine in 78% of serum specimens (range = <LOD-211 pg/mg albumin, median = 1.78 pg/mg albumin). Aflatoxin exposure did not vary by sex, age group, marital status, religion or socioeconomic characteristics. Aflatoxin exposure varied by province (p < 0.05); it was highest in Eastern (median = 7.87 pg/mg albumin) and Coast (median = 3.70 pg/mg albumin) provinces and lowest in Nyanza (median = <LOD) and Rift Valley (median = 0.70 pg/mg albumin) provinces. Our findings suggest that aflatoxin exposure is a public health problem throughout Kenya, and it could be substantially impacting human health. Wide-scale, evidence-based interventions are urgently needed to decrease exposure and subsequent health effects.
Aflatoxins are fungal toxins derived from some strains of Aspergillus flavus. They contaminate an estimated one-quarter of agricultural products worldwide, with maize, cereals and groundnuts being the most susceptible (Williams et al. 2004; Wild & Gong 2010). Although aflatoxins are ubiquitous, their growth appears to be encouraged by factors such as drought, high humidity, insect infestation and sub-optimal harvesting, drying and crop storage practices. These factors, in addition to a lack of consistently enforced aflatoxin regulatory limits, cause people in developing countries to be more adversely affected by aflatoxin exposure (Williams et al. 2004; Wild & Gong 2010).
Aflatoxins have a variety of hepatotoxic and carcinogenic characteristics. Chronic exposure has been linked to hepatocellular carcinoma (Ross et al. 1992), stunted growth (Khlangwiset et al. 2011) and impaired immunity (Jiang et al. 2005). Acute exposure (i.e., aflatoxicosis) can lead to jaundice, vomiting, abdominal pain and liver failure, with documented fatality rates as high as 40% (Centers for Disease Control and Prevention 2004; Wild & Gong 2010).
Aflatoxin exposure has been well documented in Kenya; the first reported aflatoxicosis outbreak occurred in 1981 (Ngindu et al. 1982). Multiple aflatoxicosis outbreaks have been documented since 2004, resulting in nearly 500 acute illnesses and 200 deaths (Centers for Disease Control and Prevention 2004; Azziz-Baumgartner et al. 2005). Most reported aflatoxicosis outbreaks have occurred among people living in rural, subsistence farming communities in Kenya's Eastern province and were usually associated with consuming homegrown maize (Azziz-Baumgartner et al. 2005; Mwanda et al. 2005; Daniel et al. 2011).
Like most countries, Kenya has no national aflatoxicosis surveillance. Thus, it is unknown whether aflatoxicosis outbreaks and aflatoxin exposure are truly limited to a part of the Eastern province. It is also not known whether aflatoxin exposure varies by demographic, socioeconomic or ecologic factors. This information is critical for determining the total burden of disease attributed to aflatoxin exposure and for targeting public health interventions. Thus, we conducted a cross-sectional serological and epidemiologic survey to assess aflatoxin exposure throughout Kenya and to compare aflatoxin exposure by demographic, socioeconomic and geographic characteristics.
Materials and methodsSampling
We analysed aflatoxin levels in serum specimens that were originally collected during the 2007 Kenya AIDS Indicator Survey (KAIS) (Kaiser et al. 2011). KAIS was a nationally representative, cross-sectional survey designed primarily to study the prevalence and knowledge, attitudes and beliefs regarding human immunodeficiency virus (HIV) and sexually transmitted infections in Kenya. The 2007 KAIS completed 17,940 individual interviews at 9691 households throughout Kenya. Blood specimens were provided by 15,853 individuals. Of these 15,853 blood specimens, 3180 met our inclusion criteria, which required that the sample be HIV-negative and contain ≥1 mL of sera (Figure 1).
Sampling diagram along with inclusion and exclusion criteria
We had a target sample size of 600 serum specimens for this aflatoxin exposure assessment, based on what was logistically and financially feasible. We stratified the 3180 available specimens by Kenya's eight provinces (Nyanza, Western, Rift Valley, Central, Nairobi, Eastern, North Eastern and Coast) and sex and randomly selected an approximately equal number of specimens from each of the 16 possible combinations of province and sex (n = 37 or 38). The exception was Nairobi, where only 23 male serum specimens met the inclusion criteria and thus we subsequently sampled 52 female serum specimens from Nairobi.
Of the 600 selected serum specimens, 3 specimens were of insufficient quantity/quality for laboratory analysis and 2 specimens were mislabelled, preventing us from being able to link them to demographics data. Thus, non-stratified analyses (which did not require linkage) include 597 participants; stratified analyses (which required linkage) include 595 participants.
Serum specimens were linked to household- and individual-level questionnaires that were also collected as part of the KAIS. All participants were aged 15–64 years. The questionnaires captured demographics, socioeconomic status and general health status (i.e., had they been sick in the past week, had they sought health care in the past 3 months and had anyone in their household sought health care in the past 4 weeks). Data were collected during August-November of 2007.
The 600 serum specimens selected for the aflatoxin assessment were similar in sex and age to the full KAIS sample of 15,853 specimens. There was some geographical variation. The parent KAIS selected participants from provinces with probability proportionate to size, whereas we selected an equal number of serum specimens from each province. Kenya's North-Eastern province is less populated than the rest of the country. Thus, the North-Eastern province accounted for only 5% of all KAIS participants but 12% of the serum specimens for this aflatoxin assessment.
Laboratory analysis
During initial collection, blood samples were transported to the National Reference Laboratory in Nairobi, Kenya, for HIV testing and remnant serum was stored at −70°C for future testing. HIV test results were returned to participants. The 600 serum specimens included in this study were shipped on dry ice to the Centers for Disease Control and Prevention (CDC) National Center for Environmental Health Division of Laboratory Sciences (DLS, Atlanta, Georgia, USA) for analysis. CDC DLS analysed serum specimens for aflatoxin B1 albumin adduct, which consisted of two measurements: (1) analysis of aflatoxin B1-lysine (AFB1-lys) by using LC-MS/MS (McCoy et al. 2005) and (2) albumin measurement. To allow the release of AFB1-lys from albumin, protein in serum specimens was digested in the presence of stable-isotopically labelled internal standard (2H4-AFB1-lys) in 4 hours at 37°C by the use of a commercially available mixture of proteinases (Pronase™). AFB1-lys and 2H4-AFB1-lys were then extracted by the use of mixed-mode anion exchange reversed-phase solid phase extraction (SPE). Each SPE eluate was evaporated, reconstituted in the mobile phase and injected onto a reversed-phase C18 column. AFB1-lys was chromatographically separated from other compounds by using gradient mobile phase. Both AFB1-lys and 2H4-AFB1-lys were detected with positive electrospray inonization in the selective reaction monitoring mode by using tandem quadrupole mass spectrometry (McCoy et al. 2005). Quantitation was based on peak area ratios interpolated against a seven-point aqueous linear calibration curve with 1/x weighting. The calibration range for serum AFB1-lys was 0.025–10 ng/mL. Specimens with serum AFB1-lys values of >10 ng/mL were diluted and repeated for confirmation. There are no established health-related thresholds for serum AFB1-lys concentrations. The LOD for AFB1-lys was 0.02 ng/mL. CDC DLS also analysed serum albumin on the Hitachi Modular P clinical analyzer (Indianapolis, IN, USA) by using the Roche® colorimetric assay (Indianapolis, IN, USA). The LOD for albumin was 0.2 g/dL. Human serum albumin – and subsequently albumin-corrected serum AFB-lys – has a half-life of approximately 20 days in vivo (Gan et al. 1988; Skipper & Tannenbaum 1990). Thus, the detection of AFB1-lys in this assay suggests a likelihood of exposure to aflatoxin within the previous 1–2 months.
Statistical analysis
We analysed data by using SAS version 9.3. We assigned AFB1-lys concentrations <LOD (0.02 ng/mL) a value equal to the LOD divided by the square root of 2. We normalised serum AFB1-lys concentrations to serum albumin concentrations and present aflatoxin adduct levels in units of pg/mg (McCoy et al. 2005). We calculated geometric means (GMs) by taking the antilog of the mean of natural log-transformed values. Because natural log-transformed values were not normally distributed, we compared aflatoxin concentrations between groups by using the Kruskal-Wallis and Wilcoxon Mann-Whitney tests, and we used the Pearson chi-square test to compare categorical variables. Because this investigation was hypothesis-generating, we did not adjust for multiple comparisons. We also conducted stepwise ordinal logistic regression to determine which factors were most predictive of elevated aflatoxin exposure. For this regression, aflatoxin exposure was divided into four groups, consisting of persons with exposure <LOD, and the remainder divided into exposure tertiles. We considered all variables with p < 0.10 in dichotomous analyses for inclusion.
We also compared the aflatoxin exposure levels seen here to those in other countries. However, aflatoxin exposure levels calculated by different laboratories by using different assays are not directly comparable. To correctly interpret aflatoxin data across studies, we applied a method conversion factor. Such factors have been computed previously as follows: radioimmunoassay LC-MS/MS ∼ radioimmunoassay ÷ 32); enzyme-linked immunosorbent assay (LC-MS/MS ∼ enzyme-linked immunosorbent assay ÷ 3.3); and HPLC using fluorometric detection (LC-MS/MS ∼ HPLC using fluorometric detection ÷ 0.71) (Wang et al. 1996; McCoy et al. 2008). Because of potential assay fluctuations over time, these formulas may not always capture the appropriate correction factor at the specifictimeof use; nonetheless, they provide a general idea of the relationship between assays.
Ethics statement
Participants provided informed oral consent for interviews, blood draws and storage of blood for future testing of unspecified pathogens. Survey participants were informed that future test results would not be returned to them. The survey protocol was approved by the Ethics Review Committee of the Kenya Medical Research Institute and the Institutional Review Board of the US CDC.
ResultsAflatoxin exposure
AFB1-lys adducts were detected in 78% of serum specimens (range = <LOD-9.52 ng/mL; median = 4.5 ng/mL). Albumin-corrected serum AFB1-lys levels ranged from <LOD to 211 pg/mg, with a median of 1.78 pg/mg.
Aflatoxin exposure was ubiquitous by sex, age, marital status and religion (Table 1). Aflatoxin exposure was fairly universal across several socioeconomic characteristics, including highest level of education and employment status (Table 2). There was some variation by wealth (p < 0.05); however, there was no linear trend, and median AFB1-lys levels were not statistically different between participants in the highest (2.06 pg/mg albumin) and lowest (1.53 pg/mg albumin) wealth quintiles. There was also some variation by occupation (p < 0.05); exposure was highest among participants who worked in the craft/trades (median = 4.35 pg/mg albumin) and elementary (e.g., street vendors, farm hands, and construction/manufacturing labourers; median = 3.04 pg/mg albumin) occupations.
AFB1-lys levels (pg/mg albumin) by demographic characteristics, Kenya 2007.
Totals do not always sum to 597 because of missing data.
AFB1-lys levels (pg/mg albumin) by socioeconomic characteristics, Kenya 2007.
Characteristic
na
% >LOD
Range
Median (95% CI)
75th Pct
90th Pct
GM
Overall
597
78
<LOD–211
1.78 (1.46–2.12)
5.53
15.1
2.01
Wealth quintilesb,c
Lowest
124
75
<LOD–180
1.53 (1.25–2.44)
5.06
13.7
1.89
Second
105
69
<LOD–186
1.02 (0.67–1.61)
4.68
16.2
1.46
Middle
127
72
<LOD–211
1.46 (1.05–2.40)
5.32
17.6
1.86
Fourth
99
87
<LOD–172
2.44 (2.00–4.21)
10.0
19.6
3.05
Highest
140
87
<LOD–179
2.06 (1.59–2.63)
4.89
10.1
2.17
Education
No primary
111
78
<LOD–207
1.90 (1.40–2.73)
5.12
10.5
1.89
Incomplete primary
176
74
<LOD–186
2.31 (1.46–2.96)
7.96
22.0
2.35
Complete primary
151
80
<LOD–96.9
2.00 (1.39–2.83)
5.48
14.9
2.08
Secondary
157
80
<LOD–211
1.33 (1.06–1.63)
3.72
13.0
1.71
Currently employed
Yes
402
79
<LOD–211
1.95 (1.43–2.34)
5.88
16.1
2.10
No
193
77
<LOD–179
1.63 (1.40–2.04)
5.11
13.0
1.85
Occupationc,d
Craft/trades
23
96
<LOD–96.9
4.35 (2.31–10.3)
11.8
22.1
4.78
Elementary
178
88
<LOD–211
3.04 (2.34–4.08)
9.20
20.9
3.25
Service/shop/sales
25
92
<LOD–44.1
2.91 (1.36–4.77)
5.11
10.0
2.64
Professionals
15
80
<LOD–105
1.22 (0.47–2.26)
2.26
5.60
1.41
Technicians
24
79
<LOD–11.9
1.11 (0.85–1.56)
2.48
5.50
1.25
Farm/fishery
135
64
<LOD–81.9
1.03 (0.68–1.35)
3.40
11.9
1.25
Notes: Categories in bold represent p < 0.05 for the Wilcoxon Mann-Whitney test for bivariate comparison between that category and all others. AFB1-lys, aflatoxin B1-lysine; CI, confidence interval; GM, geometric mean; Pct, percentile.
Totals do not always sum to 597 because of missing data.
Wealth index was a composite measure of the living standard of a household, calculated by using data on a household's ownership of selected assets, materials used for housing construction, water access and sanitation facilities.
p < 0.05 for between-group differences using the Kruskal-Wallis test.
Only includes occupations with ≥15 participants. Craft/trades includes miners, machine mechanics and food preparers; elementary includes street vendors, farm hands and construction/manufacturing labourers; service/shop/sales includes hairdressers, house stewards and shop assistants; professionals includes teachers and computing professionals; technicians includes engineers, business professionals and middle–level administration; farm/fishery includes farm workers.
Geographic location
Aflatoxin exposure varied by geographic location (Table 3). Serum specimens from the Eastern province had the highest exposure: the median aflatoxin adduct level (7.87 pg/mg albumin) was twofold higher than the median aflatoxin adduct level for the next highest province – the Coast province (3.70 pg/mg albumin; p < 0.01). Median aflatoxin levels were much lower in the other six provinces: Nairobi (2.44 pg/mg albumin), Central (2.33 pg/mg albumin), North-Eastern (1.40 pg/mg albumin), Western (1.28 pg/mg albumin), Rift Valley (0.70 pg/mg albumin) and Nyanza (<LOD). There was also considerable variation within provinces (Figure 2). Out of Kenya's eight provinces, four provinces (Central, Coast, North–Eastern and Western) had one district where aflatoxin was concentrated, with statistically higher levels than other districts in the same province.
Map of AFB1-lys levels (pg/mg albumin) by district, Kenya 2007. AFB1-lys, aflatoxin B1-lysine
AFB1–lys levels (pg/mg albumin) by geographic characteristics, Kenya 2007.
Characteristic
na
% >LOD
Range
Median (95% CI)
75th Pct
90th Pct
GMb
Overall
597
78
<LOD–211
1.78 (1.46–2.12)
5.53
15.1
2.01
Provincec
Eastern
75
100
0.75–186
7.87 (5.94–11.7)
16.8
34.1
8.24
Coast
73
99
<LOD–211
3.70 (2.44–5.81)
11.9
22.1
4.90
Nairobi
75
92
<LOD–179
2.44 (1.63–3.10)
5.40
11.8
2.60
Central
76
92
<LOD–49.2
2.33 (1.60–3.26)
4.55
16.1
2.39
North–Eastern
73
70
<LOD–35.5
1.40 (0.85–2.25)
4.00
7.23
1.38
Western
74
80
<LOD–36.2
1.28 (0.91–1.60)
3.04
10.7
1.47
Rift Valley
75
59
<LOD–76.7
0.70 (0.42–1.03)
1.86
5.53
NA
Nyanza
74
34
<LOD–35.1
<LOD
0.89
2.31
NA
Districtc,d
Meru North
20
100
1.19–186
11.9 (6.58–19.5)
21.8
142
13.3
Makueni
17
100
1.40–23.4
7.21 (4.29–13.3)
13.3
20.0
6.99
Thika
17
100
0.51–49.2
6.38 (3.26–11.8)
11.8
28.4
6.29
Busia
19
100
0.57–36.2
4.32 (1.33–10.6)
10.6
23.7
4.03
Garissa
30
97
<LOD–35.5
3.96 (2.31–5.12)
6.14
13.8
3.67
Mombasa
23
100
0.89–14.0
2.91 (1.95–5.22)
6.04
8.40
3.08
Nairobi
75
92
<LOD–179
2.44 (1.63–3.10)
5.40
11.8
2.60
Mandera
35
49
<LOD–10.5
0.34 (0.31–1.25)
1.46
4.32
NA
Central Kisii
46
39
<LOD–35.1
0.33 (0.31–0.68)
0.91
2.83
NA
Urban/ruralc
Urban
134
93
<LOD–207
2.23 (1.78–3.00)
5.40
9.51
2.58
Rural
461
74
<LOD–211
1.49 (1.30–2.00)
5.71
16.2
1.87
Town sizec,e
Mid–sized city
7
100
0.51–10.4
3.26 (NA)
8.68
10.4
NA
Large city
98
94
<LOD–179
2.47 (1.95–3.10)
5.40
9.51
2.70
Small town
39
72
<LOD–207
1.59 (1.22–2.61
4.32
15.7
1.71
Rural
451
75
<LOD–211
1.56 (1.33–2.00)
5.81
16.2
1.90
Notes: Categories in bold represent p < 0.05 for the Wilcoxon Mann-Whitney test for bivariate comparison between that category and all others.
Totals do not always sum to 597 because of missing data.
GM not calculated for strata with fewer than 60% persons detected.
p < 0.05 for between-group differences using the Kruskal-Wallis test.
Only includes districts with ≥15 participants. Eastern province: Meru North and Makueni; Central province: Thika; Western province: Busia; North-Eastern province: Garissa and Mandera; Coast province: Mombasa; Nairobi province: Nairobi; Nyanza province: Central Kisii.
Large city: Nairobi, Mombassa and Kisumu; mid-sized city: Nakuru, Eldoret, Thika and Nyeri.
Aflatoxin levels were higher in urban (median = 2.23 pg/mg albumin) than in rural participants (median = 1.49 pg/mg albumin; p < 0.05). Aflatoxin exposure by sex differed in Central (for men, median = 3.80 pg/mg albumin and for women, median = 1.48 pg/mg albumin; p < 0.05) and Rift Valley provinces (for men, median = <LOD and for women, median = 0.95 pg/mg albumin; p < 0.05).
The final multivariate ordinal logistic regression model indicated that province and occupation were most closely related to aflatoxin exposure; all other characteristics were not statistically significant after this adjustment (data not shown).
Health status
The three health-related variables captured by the KAIS were all related to aflatoxin exposure: participants who reported that they were sick in the past week had higher aflatoxin adduct levels (median = 2.29 pg/mg albumin) than did those who reported not being sick (median = 1.67 pg/mg albumin, p < 0.01); participants seeking health care outside the home in the past 3 months had higher aflatoxin adduct levels (median = 2.67 pg/mg albumin) than did those not seeking health care outside the home (median = 1.59 pg/mg albumin, p < 0.01) and participants living in a household in which someone (including possibly themselves) sought outpatient care during the past 4 weeks had higher aflatoxin adduct levels (median = 3.06 pg/mg albumin) than did households with no one seeking outpatient care (median = 1.61 pg/mg albumin, p < 0.01). No further information was available regarding signs and symptoms from these events.
Discussion
We found widespread aflatoxin exposure across Kenya. Over three-quarters of serum specimens had evidence of recent exposure, and this exposure persisted across the spectrum of age, sex and socioeconomic status. This widespread exposure could negatively impact health throughout Kenya. Research suggests that chronic aflatoxin exposure at the levels seen here could stunt growth (Gong et al. 2004; Khlangwiset et al. 2011) and impair immunity (Jiang et al. 2005). Furthermore, aflatoxin is a carcinogen, and cumulative exposure to any amount increases the risk of hepatocellular carcinoma (Wang et al. 1996; Williams et al. 2004; Wu et al. 2009).
During aflatoxicosis outbreaks in Kenya in 2004, 2005 and 2010, GM aflatoxin levels among patients with potential liver dysfunction ranged from 120 to 1200 pg/mg albumin (Azziz-Baumgartner et al. 2005). Although most participants in our study had much lower levels, six participants (1%) had aflatoxin adduct levels above 120 pg/mg albumin. This is particularly notable for three reasons. Firstly, this survey was conducted in 2007 – the first year since 2004 when no aflatoxicosis outbreaks were reported. Secondly, maize samples collected from Kenya's Eastern province had lower aflatoxin levels in 2007 (84% of maize samples were below 20 parts per billion) than in 2006 (only 48% of maize samples were below 20 parts per billion; unpublished data from authors). Thirdly, this survey sampled participants systematically, without regard to symptoms or expected exposure. The fact that we found extensive aflatoxin exposure during a relatively low-risk year suggests that even during optimal times, aflatoxin remains a persistent health threat in Kenya.
We found higher aflatoxin levels among persons who reported recently being sick or recently seeking health care. We do not know the details or the timing of the illness, and thus we cannot definitively link increased aflatoxin exposure to illness. It is possible that there is no causal association. However, the fact that all three of the health-related questions were associated with higher aflatoxin levels suggests a possible link. One possibility is that aflatoxin was causing liver damage or suppressing the immune system. Or, perhaps there was confounding between aflatoxin exposure, sickness and an unmeasured third variable such as diet, food security or physiological factors. We still know relatively little about the health effects of aflatoxin exposure, particularly the threshold at which physiologic changes begin to occur, and thus more research in this area is needed.
This study reinforces building evidence that aflatoxin is a problem in many African countries. After applying the appropriate method conversion factors as discussed in the “Materials and methods” section, aflatoxin exposure levels from this study (GM = 2.0 pg/mg albumin) appear to be slightly lower than levels reported previously from some other African countries. For example, Ethiopia (GM = 1 pg/mg albumin; unpublished data from authors), Gambia (published GM = 22–57 pg/mg albumin; LC-MS/MS-normalised GM = 7–80 pg/mg albumin) (Allen et al. 1992; Turner et al. 2000, 2007), Ghana (published GM = 406–455 pg/mg albumin; LC-MS/MS-normalised GM = 13–14 pg/mg albumin) (Jiang et al. 2005; Jolly et al. 2006), Benin and Togo (published GM = 33 pg/mg albumin; LC-MS/MS-normalised GM = 10 pg/mg albumin) (Gong et al. 2002, 2003) and Guinea (published GM = 9 pg/mg albumin; LC-MS/MS-normalised GM = 3 pg/mg albumin) (Turner, Sylla, Kuang, et al. 2005). It is important to note that because our study was a countrywide assessment, we selected specimens for analysis without regard to expected exposure. In contrast, most of the other studies cited here focussed on answering specific health-related research questions. Thus, they often targeted specific geographic regions and/or persons with expected higher aflatoxin exposure.
There is a large disparity in aflatoxin exposure between developed and developing countries. The largest population-based aflatoxin exposure assessment to date – and the only other national, baseline assessment that is directly comparable to our results – was conducted in the United States (Centers for Disease Control and Prevention 2012). Here, researchers measured AFB1-lys concentrations in 2104 serum samples from the 1999–2000 National Health and Nutrition Examination Survey. Using laboratory methods similar to those used here, they detected exposure in only 1.3% of the participants. The highest level found in the United States was 0.20 ng/mL – an order of magnitude lower than the median (4.5 ng/mL) reported here.
This serosurvey did not collect food samples. Maize is presumably the largest source of aflatoxin exposure in Kenya because it is the staple crop (Export Processing Zones Authority 2005) and it is very susceptible to aflatoxin contamination (Basappa 2009). Previous research from Benin and Togo found maize to be the primary risk factor for aflatoxin exposure, contributing more to elevated aflatoxin biomarker levels than do groundnuts (Egal et al. 2005). Kenya had a maize aflatoxin regulatory limit of 20 parts per billion in 2007; however, this can be difficult to enforce. Small-scale farmers produce three-fourths of Kenyan maize (Export Processing Zones Authority 2005). Small-scale farmers sometimes sell their maize to market vendors (Lewis et al. 2005); this can allow contaminated maize to enter the market distribution system and find its way to commercial millers, where maize is milled, packaged and distributed throughout the country. This may be one reason why we found aflatoxin exposure in urban areas, where persons would presumably be purchasing their maize rather than growing it themselves.
These data have some limitations. We selected serum specimens in an attempt to provide an indication of exposure throughout Kenya. However, they are not a statistically derived sample and thus we cannot make national estimates. Limited data were available on aflatoxin-related health outcomes or on risk factors for aflatoxin exposure, because the original survey was designed to study HIV. Finally, only one-fifth of participants providing a blood specimen for the KAIS were eligible for inclusion in the aflatoxin analysis. It is unlikely that aflatoxin exposure was related to the volume of available serum; however, it is possible that the aflatoxin level may have been related to HIV status. Evidence suggests that aflatoxin levels are higher among persons with HIV (Obuseh et al. 2011); thus, our results may underestimate the true burden of aflatoxin in Kenya.
Conclusions
Our data demonstrate an urgent need to implement evidence-based interventions in Kenya to decrease aflatoxin exposure and subsequently avert adverse health effects. We found that aflatoxin distribution was not homogenous across province. Thus, these data should be used to target interventions to specific regions of high exposure. Various interventions have demonstrated effectiveness in controlled studies. These include planting resistant cultivars (Hell et al. 2008), spraying atoxigenic strains of Aspergillus flavus on maize to crowd out toxigenic strains (Cotty et al. 2007; Yin et al. 2008) and developing strategies to assist small-scale farmers with appropriate drying and storage techniques (Turner, Sylla, Gong, et al. 2005; Hell et al. 2008). However, research demonstrating the effectiveness of these and other interventions in real life and in various populations is limited. Resources are needed to implement and evaluate these interventions in field studies in Kenya to determine their effectiveness in reducing human aflatoxin biomarkers; then, successful interventions can be scaled-up.
We documented exposure across Kenya, including in regions with no prior evidence of exposure and no documented aflatoxicosis outbreaks. Thus, this raises the question as to whether similar exposures may be occurring in neighbouring countries with a similar lack of previous exposure history. Similar serosurveys in other African countries that rely on aflatoxin-susceptible crops such as maize and groundnuts are warranted. With planning across public health sectors, other countries may also be able to reduce costs of such assessments by leveraging nationally representative serosurveys, such as the HIV prevalence survey that was leveraged here.
Acknowledgements
This study was funded through the United States President's Emergency Plan for AIDS Relief and the Centers for Disease Control and Prevention (CDC), Department of Health and Human Services. We thank the following organisations for their assistance in completing this research: the Government of Kenya, Kenya Ministry of Public Health and Sanitation, Kenya National HIV Reference Laboratory, CDC Global Disease Detection Division and the CDC Division of Global HIV/AIDS within CDC-Kenya.
Declaration of interest: The sponsor of the study had some role in study design and data collection; they had no role in data analysis, data interpretation, or manuscript preparation. The corresponding author had full access to all the data in the study and had final responsibility for the decision to submit for publication. We declare that we have no conflicts of interest.
ReferencesAllenSJWildCPWheelerJGRileyEMMontesanoRBennettSWhittleHCHallAJGreenwoodBMAflatoxin exposure, malaria and hepatitis B infection in rural Gambian childrenTrans R Soc Trop Med Hyg1992864264301440826Azziz-BaumgartnerELindbladeKGiesekerKRogersHSKieszakSNjapauHSchleicherRMcCoyLFMisoreADeCockKCase-control study of an acute aflatoxicosis outbreak, Kenya, 2004Environ Health Perspect20051131779178316330363BasappaSCAflatoxins: formations, analysis, and control2009OxfordAlpha Science International, Ltd.Centers for Disease Control and PreventionOutbreak of aflatoxin poisoning – eastern and central provinces, Kenya, January-July 2004MMWR Morb Mortal Wkly Rep.20045379079315343146Centers for Disease Control and PreventionNational Health and Nutrition Examination Survey: aflatoxin B1-lysine concentration in serum (SSAFB_A)2012[Internet]. [cited 2012 Oct 17]. Available from: http://www.cdc.gov/nchs/nhanes/nhanes1999-2000/SSAFB_A.htm.CottyPJAntillaLWakelynPJVincentC.GoettelN.LazarovitisG.Competitive exclusion of aflatoxin producers: farmer driven research and developmentBiological control: a global perspective2007WallingfordCAB International241253DanielJHLewisLWRedwoodYAKieszakSBreimanRFFlandersWDBellCMwihiaJOganaGLikimaniSComprehensive assessment of maize aflatoxin levels in Eastern Kenya, 2005–2007Environ Health Perspect20111191794179921843999EgalSHounsaAGongYYTurnerPCWildCPHallAJHellKCardwellKFDietary exposure to aflatoxin from maize and groundnut in young children from Benin and Togo, West AfricaInt J Food Microbiol200510421522415979184Export Processing Zones AuthorityGrain Production in Kenya: 2005. [Internet]2005[cited 2012 Oct 25]. Available from: http://www.epzakenya.com/UserFiles/files/GrainReport.pdfGanLSSkipperPLPengXCGroopmanJDChenJSWoganGNTannenbaumSRSerum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1Carcinogenesis19889132313253133131GongYYCardwellKHounsaAEgalSTurnerPCHallAJWildCPDietary aflatoxin exposure and impaired growth in young children from Benin and Togo: cross sectional studyBMJ2002325202112098724GongYYEgalSHounsaATurnerPCHallAJCardwellKFWildCPDeterminants of aflatoxin exposure in young children from Benin and Togo, West Africa: the critical role of weaningInt J Epidemiol20033255656212913029GongYHounsaAEgalSTurnerPCSutcliffeAEHallAJCardwellKWildCPPostweaning exposure to aflatoxin results in impaired child growth: a longitudinal study in Benin, West AfricaEnviron Health Perspect20041121334133815345349HellKFandohanPBandyopadhyayRKiewnickSSikoraRCottyPLeslieJ.BandyopadhyayR.ViscontiA.Pre- and post-harvest management of aflatoxin in maize: an African perspectiveMycotoxins: detection methods, management, public health, and agricultural trade2008WallingfordCAB International219229JiangYJollyPEEllisWOWangJSPhillipsTDWilliamsJHAflatoxin B1 albumin adduct levels and cellular immune status in GhanaiansInt Immunol.20051780781415944194JollyPJiangYEllisWAwuahRNneduOPhillipsTWangJSAfriyie-GyawuETangLPersonSDeterminants of aflatoxin levels in Ghanaians: sociodemographic factors, knowledge of aflatoxin and food handling and consumption practicesInt J Hyg Environ Health200620934535816644281KaiserRBunnellRHightowerAKimAACherutichPMwangiMOluochTDadabhaiSMureithiPMugoNFactors associated with HIV infection in married or cohabitating couples in Kenya: results from a nationally representative studyPLoS One20116e17842e1784221423615KhlangwisetPShephardGSWuFAflatoxins and growth impairment: a reviewCrit Rev Toxicol20114174075521711088LewisLOnsongoMNjapauHSchurz-RogersHLuberGKieszakSNyamongoJBackerLDahiyeAMMisoreAAflatoxin contamination of commercial maize products during an outbreak of acute aflatoxicosis in eastern and central KenyaEnviron Health Perspect20051131763176716330360McCoyLFSchollPFSchleicherRLGroopmanJDPowersCDPfeifferCMAnalysis of aflatoxin B1-lysine adduct in serum using isotope-dilution liquid chromatography/tandem mass spectrometryRapid Commun Mass Spectrom2005192203221016015671McCoyLFSchollPFSutcliffeAEKieszakSMPowersCDRogersHSGongYYGroopmanJDWildCPSchleicherRLHuman aflatoxin albumin adducts quantitatively compared by ELISA, HPLC with fluorescence detection, and HPLC with isotope dilution mass spectrometryCancer Epidemiol Biomarkers Prev2008171653165718628416MwandaOWOtienoCFOmongeEAcute aflatoxicosis: case reportEast Afr Med J20058232032416175785NginduAJohnsonBKKenyaPRNgiraJAOchengDMNandwaHOmondiTNJansenAJNgareWKavitiJNOutbreak of acute hepatitis caused by aflatoxin poisoning in KenyaLancet19821134613486123648ObusehFAJollyPEKulczyckiAEhiriJWaterborJDesmondRAPrekoPOJiangYPiyathilakeCJAflatoxin levels, plasma vitamins A and E concentrations, and their association with HIV and hepatitis B virus infections in Ghanaians: a cross-sectional studyJ Int AIDS Soc2011145322078415RossRKYuanJMYuMCWoganGNQianGSTuJTGroopmanJDGaoYTHendersonBEUrinary aflatoxin biomarkers and risk of hepatocellular carcinomaLancet19923399439461348796SkipperPLTannenbaumSRProtein adducts in the molecular dosimetry of chemical carcinogensCarcinogenesis1990115075182182215TurnerPCCollinsonACCheungYBGongYHallAJPrenticeAMWildCPAflatoxin exposure in utero causes growth faltering in Gambian infantsInt J Epidemiol2007361119112517576701TurnerPCMendyMWhittleHFortuinMHallAJWildCPHepatitis B infection and aflatoxin biomarker levels in Gambian childrenTrop Med Int Health2000583784111169271TurnerPCSyllaAGongYYDialloMSSutcliffeAEHallAJWildCPReduction in exposure to carcinogenic aflatoxins by postharvest intervention measures in west Africa: a community-based intervention studyLancet20053651950195615936422TurnerPCSyllaAKuangSYMarchantCLDialloMSHallAJGroopmanJDWildCPAbsence of TP53 codon 249 mutations in young Guinean children with high aflatoxin exposureCancer Epidemiol Biomarkers Prev2005142053205516103461WangLYHatchMChenCJLevinBYouSLLuSNWuMHWuWPWangLWWangQAflatoxin exposure and risk of hepatocellular carcinoma in TaiwanInt J Cancer1996676206258782648WildCPGongYYMycotoxins and human disease: a largely ignored global health issueCarcinogenesis201031718219875698WilliamsJHPhillipsTDJollyPEStilesJKJollyCMAggarwalDHuman aflatoxicosis in developing countries: a review of toxicology, exposure, potential health consequences, and interventionsAm J Clin Nutr2004801106112215531656WuHCWangQYangHIAhsanHTsaiWYWangLYChenSYChenCJSantellaRMAflatoxin B1 exposure, hepatitis B virus infection, and hepatocellular carcinoma in TaiwanCancer Epidemiol Biomarkers Prev20091884685319273485YinYNYanLYJiangJHMaZHBiological control of aflatoxin contamination of cropsJ Zhejiang Univ Sci B2008978779218837105